NEW HAVEN, Conn. (Legal Newsline) — Delaware Attorney General Matt Denn announced Dec. 15 that he had joined with 19 other state attorneys general in filing a federal lawsuit against Heritage Pharmaceuticals Inc., Auribindo Pharma USA Inc., Citron Pharma LLC, Mayne Pharma (USA) Inc., Mylan Pharmaceuticals Inc. and Teva Pharmaceuticals USA Inc.
The states allege the companies entered into a
multitude of illegal conspiracies to restrain trade, inflate and manipulate
prices and reduce competition within the United States for the drugs doxycycline
hyclate delayed release and glyburide.
The state of Connecticut first looked into the matter in
July 2014, attempting to discern the reason for suspicious price increases of
certain generic pharmaceuticals. The case turned into an ongoing issue related
to a number of generic drugs. According to the new lawsuit, these companies
were involved in a well-coordinated and long-running series of conspiracies to
fix prices and allocate markets.
Joining Delaware in the lawsuit are Connecticut, Florida,
Hawaii, Idaho, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland,
Massachusetts, Minnesota, Nevada, New York, North Dakota, Ohio, Pennsylvania,
Virginia and Washington.
The lawsuit was filed in the U.S. District Court for the
District of Connecticut.